Skip to content

Effects of Low Signal-to-noise Ratio White Noise on Individuals with Insomnia Disorder and the Underlying Neural Mechanisms

Effects of Low Signal-to-noise Ratio White Noise on Individuals with Insomnia Disorder and the Underlying Neural Mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600120408
Enrollment
Unknown
Registered
2026-03-13
Start date
2026-03-16
Completion date
Unknown
Last updated
2026-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic insomnia disorder

Interventions

Patients with chronic insomnia disorder:Low signal-to-noise ratio white noise intervention

Sponsors

Hefei Fourth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Meets the diagnostic criteria for chronic insomnia disorder according to the International Classification of Sleep Disorders, 3rd Edition (ICSD-3); 2. Aged 18 to 60 years, no gender restrictions; 3. Insomnia Severity Index (ISI) >= 15 points; 4. Regular bedtime between 8:30 PM and midnight, with a consistent sleep duration of 6.5 to 9 hours; 5. Voluntary participation and signed informed consent.

Exclusion criteria

Exclusion criteria: 1. Individuals with neurological disorders (e.g., epilepsy, stroke) or psychiatric disorders (including depression, anxiety disorders, schizophrenia, etc.), with a Hamilton Depression Rating Scale-24 (HAMD-24) score >=14 or a Hamilton Anxiety Rating Scale (HAMA) score >=13; 2.Presence of severe sleep apnea (apnea-hypopnea index >=30 events/hour), restless legs syndrome, narcolepsy, or other sleep disorders; 3. History of alcohol or substance abuse within the past 6 months; 4.Use of any sleep-affecting medications, health supplements, or receipt of other insomnia treatments within 2 weeks prior to enrollment; 5.Pregnant or lactating women, or those planning pregnancy during the study period and unwilling to use effective contraception; 6.Presence of MRI contraindications (e.g., metallic implants, severe claustrophobia) or inability to undergo fNIRS/ERP testing for other reasons; 7. Other circumstances deemed unsuitable for trial participation by the investigator.

Design outcomes

Primary

MeasureTime frame
Objective sleep measures;

Secondary

MeasureTime frame
Resting state brain functional data;Functional near - infrared spectroscopy data;Event-related potential data;Depression and anxiety symptoms;Insomnia Severity;Sleep quality;Subjective sleep quality;

Countries

China

Contacts

Public ContactDaomin Zhu

Hefei Fourth People’s Hospital

daominzhu1977@126.com+86 551 6557 6913

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 20, 2026